APA (7th ed.) Citation

DN, F., PJ, G., WM, L., LR, D., SL, C., RM, H., . . . TO, H. (2024). Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: A report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 116(6), 885. https://doi.org/10.1093/jnci/djae062

Chicago Style (17th ed.) Citation

DN, Friedman, et al. "Impact of Risk-based Therapy on Late Morbidity and Mortality in Neuroblastoma Survivors: A Report from the Childhood Cancer Survivor Study." Journal of the National Cancer Institute 116, no. 6 (2024): 885. https://doi.org/10.1093/jnci/djae062.

MLA (9th ed.) Citation

DN, Friedman, et al. "Impact of Risk-based Therapy on Late Morbidity and Mortality in Neuroblastoma Survivors: A Report from the Childhood Cancer Survivor Study." Journal of the National Cancer Institute, vol. 116, no. 6, 2024, p. 885, https://doi.org/10.1093/jnci/djae062.